Using the Pharmaceutical Collection Database to identify patient adherence to oral hypoglycaemic medicines

Identifies levels of sub-optimal adherence to oral hypoglycaemic medicines among people with type 2 diabetes, and those patient groups who may need additional adherence support. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for...

Full description

Saved in:
Bibliographic Details
Published inJournal of primary health care Vol. 11; no. 3; pp. 265 - 274
Main Authors Kharjul, Mangesh D, Cameron, Claire, Braund, Rhiannon
Format Journal Article
LanguageEnglish
Published Australia 01.09.2019
Subjects
Hypoglycemic agents
Non-insulin-dependent diabetes
Patient compliance
Treatment
Online AccessGet full text

Cover

Abstract Identifies levels of sub-optimal adherence to oral hypoglycaemic medicines among people with type 2 diabetes, and those patient groups who may need additional adherence support. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
AbstractList INTRODUCTION Poor adherence to oral hypoglycaemic medicines is a key contributor to therapy failure and sub-optimal glycaemic control among people with type 2 diabetes. It is unclear how commonly non-adherence to oral hypoglycaemics occurs in the general population. This information is essential to design and implement local adherence strategies. AIM This study aimed to determine levels of sub-optimal adherence and identify patient groups who may need additional adherence support. METHODS The dispensing data of 340,283 patients from one District Health Board was obtained from the Pharmaceutical Collection Database for the period 2008-15. Of these, 12,405 patients received oral hypoglycaemic therapy during the study period. The proportion of days covered (PDC) was calculated for patients with complete data and a PDC value of ≥80% was used to indicate sufficient adherence. Patient demographics (gender, ethnicity, age, socioeconomic status) and therapy type (mono- or combination) were described. RESULTS Overall, 54.5% of the patients were found to have a PDC of <80% and so were considered non-adherent. Non-adherence was significantly higher in patients receiving combination oral hypoglycaemic therapy than monotherapy; in male patients; in New Zealand Māori patients; and in patients with higher socioeconomic deprivation. DISCUSSION In the study region, non-adherence to oral hypoglycaemic medicines was significant and widespread. Identification of such patients is important so that strategies to enhance adherence can be implemented. Prescribers need to be encouraged to optimise monotherapy before the addition of another oral hypoglycaemic, and adherence support services should be offered not only to older patients.
ABSTRACT INTRODUCTIONPoor adherence to oral hypoglycaemic medicines is a key contributor to therapy failure and sub-optimal glycaemic control among people with type 2 diabetes. It is unclear how commonly non-adherence to oral hypoglycaemics occurs in the general population. This information is essential to design and implement local adherence strategies. AIMThis study aimed to determine levels of sub-optimal adherence and identify patient groups who may need additional adherence support. METHODSThe dispensing data of 340,283 patients from one District Health Board was obtained from the Pharmaceutical Collection Database for the period 2008–15. Of these, 12,405 patients received oral hypoglycaemic therapy during the study period. The proportion of days covered (PDC) was calculated for patients with complete data and a PDC value of ≥80% was used to indicate sufficient adherence. Patient demographics (gender, ethnicity, age, socioeconomic status) and therapy type (mono- or combination) were described. RESULTSOverall, 54.5% of the patients were found to have a PDC of <80% and so were considered non-adherent. Non-adherence was significantly higher in patients receiving combination oral hypoglycaemic therapy than monotherapy; in male patients; in New Zealand Māori patients; and in patients with higher socioeconomic deprivation. DISCUSSIONIn the study region, non-adherence to oral hypoglycaemic medicines was significant and widespread. Identification of such patients is important so that strategies to enhance adherence can be implemented. Prescribers need to be encouraged to optimise monotherapy before the addition of another oral hypoglycaemic, and adherence support services should be offered not only to older patients.
Identifies levels of sub-optimal adherence to oral hypoglycaemic medicines among people with type 2 diabetes, and those patient groups who may need additional adherence support. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
Author Braund, Rhiannon
Kharjul, Mangesh D
Cameron, Claire
Author_xml – sequence: 1
  fullname: Kharjul, Mangesh D
– sequence: 2
  fullname: Cameron, Claire
– sequence: 3
  fullname: Braund, Rhiannon
BackLink https://natlib-primo.hosted.exlibrisgroup.com/primo-explore/search?query=any,contains,999018406402837&tab=innz&search_scope=INNZ&vid=NLNZ&offset=0$$DView this record in NLNZ
https://www.ncbi.nlm.nih.gov/pubmed/32171380$$D View this record in MEDLINE/PubMed
BookMark eNo9kEtLAzEUhYMo1hf-Awm40E01ryaTpdRHBUEXuh4yyW2bMpPUSQrWX2-0tXdzLtzvHLjnGO2HGAChc0puKFH0djKmmlC1h44oVWwo6Uju73YpBugspQUpIyQnjB2iAWdUUV6RI7T4SD7McJ4DfpubvjMWVtlb0-JxbFuw2ceA7002jUmAc8TeQch-usZLk31ZsXFz6CHYv2vsi3O-XsZZu7YGOm9xB85bHyCdooOpaROcbfUEfTw-vI8nw5fXp-fx3cvQcsHysOGqYcoAYwqodkCUlsIoyYQcUQquoVrLxmltmqkzXAhnOR0VumqEqOSIn6DrTe6yj58rSLnufLLQtiZAXKWacaVkCVWqoFcb1PYxpR6m9bL3nenXNSX1b7f1tttCXmxDV035aMf9N1mAyw0Q2vBd--Dgq6jWxV0JIgVhFVf8BxU1f_Y
CitedBy_id crossref_primary_10_1111_bcp_16069
crossref_primary_10_1071_HCv11n3_ED1
crossref_primary_10_1016_j_rcsop_2022_100175
crossref_primary_10_1371_journal_pone_0271650
crossref_primary_10_1071_HC20043
crossref_primary_10_1186_s41043_023_00459_2
Cites_doi 10.1331/JAPhA.2012.11088
10.1056/NEJMra050100
10.1331/JAPhA.2012.10183
10.2337/dc14-2142
10.1097/00005650-200209000-00009
10.1016/j.dsx.2014.09.001
10.1016/S2213-8587(17)30100-6
10.1016/j.sapharm.2013.08.006
10.2147/PPA.S40736
10.2337/dc15-1194
10.1136/jech.2009.099101
10.1071/HC13234
10.1186/s12913-014-0532-2
10.1007/s40273-015-0268-9
10.1007/s11096-018-0606-z
10.1007/s40266-013-0074-z
10.1345/aph.1E438
10.4103/2277-9531.127541
10.1002/pds.1698
10.1016/j.clinthera.2006.09.021
10.1590/0102-311x00136216
10.2147/PPA.S69651
10.1186/s12913-016-1489-0
10.1016/j.maturitas.2018.02.008
10.1016/j.jsps.2015.02.023
10.2337/dc14-2098
10.1345/aph.1H018
10.1002/pds.1230
10.1111/jcpt.12219
10.1185/03007990903126833
10.1111/j.1524-4733.2009.00543.x
10.1007/s11096-014-9913-1
10.1111/j.1365-2125.2012.04167.x
10.1016/j.jcjd.2012.07.002
10.1016/j.jclinepi.2004.10.012
10.18553/jmcp.2012.18.7.516
10.1371/journal.pone.0080436
10.1111/j.1524-4733.2006.00139.x
10.1136/jech-2013-202744
10.1111/dme.12651
10.1258/jtt.2012.gth105
10.1016/j.sapharm.2015.11.001
10.4065/mcp.2010.0575
10.1097/MLR.0b013e31817924d2
ContentType Journal Article
DBID GOM
LETOP
NPM
AAYXX
CITATION
7X8
DOI 10.1071/HC19017
DatabaseName Index New Zealand
Index New Zealand (Open Access)
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1172-6156
EndPage 274
ExternalDocumentID 10_1071_HC19017
32171380
999018406402837
Genre Journal Article
GroupedDBID ---
04C
44B
5VS
AAWTL
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
BMSDO
DIK
EBD
EBS
EIHBH
EJD
F5P
GOM
GROUPED_DOAJ
GX1
IPNFZ
KQ8
LETOP
OK1
P2P
RCO
RIG
RNS
SJN
TR2
0R~
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c342t-b37b27ae227e19de07964a76246511edb1996bd99abfda344dc3152278b448653
ISSN 1172-6164
1172-6156
IngestDate Thu Apr 11 21:41:24 EDT 2024
Fri Aug 23 01:22:57 EDT 2024
Thu May 23 23:50:17 EDT 2024
Thu Sep 21 18:41:34 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c342t-b37b27ae227e19de07964a76246511edb1996bd99abfda344dc3152278b448653
Notes Archived by the National Library of New Zealand.
Includes chart, references, tables
Includes links to related electronic resources
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1071/HC19017
PMID 32171380
PQID 2377679677
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2377679677
crossref_primary_10_1071_HC19017
pubmed_primary_32171380
nlnz_indexnz_999018406402837
PublicationCentury 2000
PublicationDate 2019-09-01
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: 2019-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
PublicationTitle Journal of primary health care
PublicationTitleAlternate J Prim Health Care
PublicationYear 2019
References HC19017R29
Caetano (HC19017R34) 2006; 28
Assawasuwannakit (HC19017R45) 2015; 40
Haynes (HC19017R51) 2008
Vrijens (HC19017R47) 2012; 73
Zhang (HC19017R3) 2017; 5
Kirkman (HC19017R8) 2015; 38
Karve (HC19017R35) 2009; 12
Karve (HC19017R32) 2009; 25
Normansell (HC19017R49) 2017; 4
Cadarette (HC19017R26) 2015; 68
van Driel (HC19017R50) 2016; 12
Wishah (HC19017R53) 2015; 9
Brown (HC19017R16) 2011; 86
Grant (HC19017R2) 2015; 38
Zullig (HC19017R10) 2015; 9
Farmer (HC19017R11) 2016; 39
Gavrielov-Yusim (HC19017R24) 2014; 68
Asif (HC19017R7) 2014; 3
Karve (HC19017R39) 2008; 46
Butt (HC19017R12) 2016; 24
Peterson (HC19017R30) 2007; 10
Mazzali (HC19017R28) 2016; 16
Tan (HC19017R21) 2014; 10
Hatah (HC19017R22) 2014; 36
Adler (HC19017R48) 2017; 4
Krass (HC19017R9) 2015; 32
Vink (HC19017R36) 2009; 18
Sattler (HC19017R41) 2013; 30
Robin DiMatteo (HC19017R17) 2002; 40
Thent (HC19017R6) 2013; 8
Lim (HC19017R54) 2016; 29
Kharjul (HC19017R23) 2018; 40
Kalogianni (HC19017R18) 2011; 5
Osterberg (HC19017R15) 2005; 353
Odegard (HC19017R58) 2005; 39
Rosella (HC19017R27) 2014; 14
Korcegez (HC19017R13) 2017; 23
Chisholm-Burns (HC19017R33) 2012; 52
Omran (HC19017R56) 2012; 36
Kozma (HC19017R37) 2013; 7
Jarab (HC19017R57) 2012; 18
Seib (HC19017R5) 2018; 111
Schneeweiss (HC19017R25) 2005; 58
Andrade (HC19017R38) 2006; 15
Bagge (HC19017R46) 2013; 5
Nieuwlaat (HC19017R52) 2014; 11
Jacobs (HC19017R59) 2012; 52
Hess (HC19017R31) 2006; 40
Seuring (HC19017R4) 2015; 33
Ganguli (HC19017R19) 2016; 10
Jatrana (HC19017R43) 2011; 65
Cassimatis (HC19017R55) 2012; 18
Zhu (HC19017R40) 2014; 2014
Norris (HC19017R44) 2016; 12
References_xml – volume: 52
  start-page: 823
  year: 2012
  ident: HC19017R33
  publication-title: J Am Pharm Assoc.
  doi: 10.1331/JAPhA.2012.11088
  contributor:
    fullname: Chisholm-Burns
– volume: 29
  start-page: 595
  year: 2016
  ident: HC19017R54
  publication-title: Pak J Pharm Sci.
  contributor:
    fullname: Lim
– volume: 353
  start-page: 487
  year: 2005
  ident: HC19017R15
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMra050100
  contributor:
    fullname: Osterberg
– volume: 52
  start-page: 613
  year: 2012
  ident: HC19017R59
  publication-title: J Am Pharm Assoc.
  doi: 10.1331/JAPhA.2012.10183
  contributor:
    fullname: Jacobs
– volume: 38
  start-page: 6
  year: 2015
  ident: HC19017R2
  publication-title: Diabetes Care.
  doi: 10.2337/dc14-2142
  contributor:
    fullname: Grant
– volume: 4
  year: 2017
  ident: HC19017R49
  publication-title: Cochrane Database Syst Rev.
  contributor:
    fullname: Normansell
– volume: 40
  start-page: 794
  year: 2002
  ident: HC19017R17
  publication-title: Med Care.
  doi: 10.1097/00005650-200209000-00009
  contributor:
    fullname: Robin DiMatteo
– volume: 9
  start-page: 271
  year: 2015
  ident: HC19017R53
  publication-title: Diabetes Metab Syndr.
  doi: 10.1016/j.dsx.2014.09.001
  contributor:
    fullname: Wishah
– volume: 5
  start-page: 404
  year: 2017
  ident: HC19017R3
  publication-title: Lancet Diabetes Endocrinol.
  doi: 10.1016/S2213-8587(17)30100-6
  contributor:
    fullname: Zhang
– volume: 10
  start-page: 608
  year: 2014
  ident: HC19017R21
  publication-title: Res Social Adm Pharm.
  doi: 10.1016/j.sapharm.2013.08.006
  contributor:
    fullname: Tan
– volume: 2014
  start-page: 1294
  year: 2014
  ident: HC19017R40
  publication-title: AMIA Annu Symp Proc.
  contributor:
    fullname: Zhu
– volume: 7
  start-page: 509
  year: 2013
  ident: HC19017R37
  publication-title: Patient Prefer Adherence.
  doi: 10.2147/PPA.S40736
  contributor:
    fullname: Kozma
– year: 2008
  ident: HC19017R51
  publication-title: Cochrane Database Syst Rev.
  contributor:
    fullname: Haynes
– volume: 39
  start-page: 258
  year: 2016
  ident: HC19017R11
  publication-title: Diabetes Care.
  doi: 10.2337/dc15-1194
  contributor:
    fullname: Farmer
– volume: 65
  start-page: 454
  year: 2011
  ident: HC19017R43
  publication-title: J Epidemiol Community Health.
  doi: 10.1136/jech.2009.099101
  contributor:
    fullname: Jatrana
– volume: 5
  start-page: 234
  year: 2013
  ident: HC19017R46
  publication-title: J Prim Health Care.
  doi: 10.1071/HC13234
  contributor:
    fullname: Bagge
– volume: 14
  start-page: 532
  year: 2014
  ident: HC19017R27
  publication-title: BMC Health Serv Res.
  doi: 10.1186/s12913-014-0532-2
  contributor:
    fullname: Rosella
– volume: 33
  start-page: 811
  year: 2015
  ident: HC19017R4
  publication-title: Pharmacoeconomics.
  doi: 10.1007/s40273-015-0268-9
  contributor:
    fullname: Seuring
– volume: 40
  start-page: 354
  year: 2018
  ident: HC19017R23
  publication-title: Int J Clin Pharm.
  doi: 10.1007/s11096-018-0606-z
  contributor:
    fullname: Kharjul
– volume: 30
  start-page: 383
  year: 2013
  ident: HC19017R41
  publication-title: Drugs Aging.
  doi: 10.1007/s40266-013-0074-z
  contributor:
    fullname: Sattler
– volume: 39
  start-page: 433
  year: 2005
  ident: HC19017R58
  publication-title: Ann Pharmacother.
  doi: 10.1345/aph.1E438
  contributor:
    fullname: Odegard
– volume: 3
  start-page: 1
  year: 2014
  ident: HC19017R7
  publication-title: J Educ Health Promot.
  doi: 10.4103/2277-9531.127541
  contributor:
    fullname: Asif
– volume: 18
  start-page: 159
  year: 2009
  ident: HC19017R36
  publication-title: Pharmacoepidemiol Drug Saf.
  doi: 10.1002/pds.1698
  contributor:
    fullname: Vink
– volume: 23
  start-page: 573
  year: 2017
  ident: HC19017R13
  publication-title: J Manag Care Spec Pharm.
  contributor:
    fullname: Korcegez
– volume: 28
  start-page: 1411
  year: 2006
  ident: HC19017R34
  publication-title: Clin Ther.
  doi: 10.1016/j.clinthera.2006.09.021
  contributor:
    fullname: Caetano
– ident: HC19017R29
  doi: 10.1590/0102-311x00136216
– volume: 5
  start-page: 157
  year: 2011
  ident: HC19017R18
  publication-title: Health Sci J.
  contributor:
    fullname: Kalogianni
– volume: 9
  start-page: 139
  year: 2015
  ident: HC19017R10
  publication-title: Patient Prefer Adherence.
  doi: 10.2147/PPA.S69651
  contributor:
    fullname: Zullig
– volume: 16
  start-page: 234
  year: 2016
  ident: HC19017R28
  publication-title: BMC Health Serv Res.
  doi: 10.1186/s12913-016-1489-0
  contributor:
    fullname: Mazzali
– volume: 111
  start-page: 1
  year: 2018
  ident: HC19017R5
  publication-title: Maturitas.
  doi: 10.1016/j.maturitas.2018.02.008
  contributor:
    fullname: Seib
– volume: 10
  start-page: 711
  year: 2016
  ident: HC19017R19
  publication-title: Patient Prefer Adherence.
  contributor:
    fullname: Ganguli
– volume: 68
  start-page: 232
  year: 2015
  ident: HC19017R26
  publication-title: Can J Hosp Pharm.
  contributor:
    fullname: Cadarette
– volume: 24
  start-page: 40
  year: 2016
  ident: HC19017R12
  publication-title: Saudi Pharm J.
  doi: 10.1016/j.jsps.2015.02.023
  contributor:
    fullname: Butt
– volume: 38
  start-page: 604
  year: 2015
  ident: HC19017R8
  publication-title: Diabetes Care.
  doi: 10.2337/dc14-2098
  contributor:
    fullname: Kirkman
– volume: 40
  start-page: 1280
  year: 2006
  ident: HC19017R31
  publication-title: Ann Pharmacother.
  doi: 10.1345/aph.1H018
  contributor:
    fullname: Hess
– volume: 15
  start-page: 565
  year: 2006
  ident: HC19017R38
  publication-title: Pharmacoepidemiol Drug Saf.
  doi: 10.1002/pds.1230
  contributor:
    fullname: Andrade
– volume: 40
  start-page: 24
  year: 2015
  ident: HC19017R45
  publication-title: J Clin Pharm Ther.
  doi: 10.1111/jcpt.12219
  contributor:
    fullname: Assawasuwannakit
– volume: 25
  start-page: 2303
  year: 2009
  ident: HC19017R32
  publication-title: Curr Med Res Opin.
  doi: 10.1185/03007990903126833
  contributor:
    fullname: Karve
– volume: 12
  start-page: 989
  year: 2009
  ident: HC19017R35
  publication-title: Value Health.
  doi: 10.1111/j.1524-4733.2009.00543.x
  contributor:
    fullname: Karve
– volume: 36
  start-page: 503
  year: 2014
  ident: HC19017R22
  publication-title: Int J Clin Pharm.
  doi: 10.1007/s11096-014-9913-1
  contributor:
    fullname: Hatah
– volume: 73
  start-page: 691
  year: 2012
  ident: HC19017R47
  publication-title: Br J Clin Pharmacol.
  doi: 10.1111/j.1365-2125.2012.04167.x
  contributor:
    fullname: Vrijens
– volume: 36
  start-page: 292
  year: 2012
  ident: HC19017R56
  publication-title: Can J Diab.
  doi: 10.1016/j.jcjd.2012.07.002
  contributor:
    fullname: Omran
– volume: 58
  start-page: 323
  year: 2005
  ident: HC19017R25
  publication-title: J Clin Epidemiol.
  doi: 10.1016/j.jclinepi.2004.10.012
  contributor:
    fullname: Schneeweiss
– volume: 12
  year: 2016
  ident: HC19017R50
  publication-title: Cochrane Database Syst Rev.
  contributor:
    fullname: van Driel
– volume: 18
  start-page: 516
  year: 2012
  ident: HC19017R57
  publication-title: J Manag Care Pharm.
  doi: 10.18553/jmcp.2012.18.7.516
  contributor:
    fullname: Jarab
– volume: 8
  year: 2013
  ident: HC19017R6
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0080436
  contributor:
    fullname: Thent
– volume: 11
  year: 2014
  ident: HC19017R52
  publication-title: Cochrane Database Syst Rev.
  contributor:
    fullname: Nieuwlaat
– volume: 10
  start-page: 3
  year: 2007
  ident: HC19017R30
  publication-title: Value Health.
  doi: 10.1111/j.1524-4733.2006.00139.x
  contributor:
    fullname: Peterson
– volume: 68
  start-page: 283
  year: 2014
  ident: HC19017R24
  publication-title: J Epidemiol Community Health.
  doi: 10.1136/jech-2013-202744
  contributor:
    fullname: Gavrielov-Yusim
– volume: 32
  start-page: 725
  year: 2015
  ident: HC19017R9
  publication-title: Diabet Med.
  doi: 10.1111/dme.12651
  contributor:
    fullname: Krass
– volume: 18
  start-page: 447
  year: 2012
  ident: HC19017R55
  publication-title: J Telemed Telecare.
  doi: 10.1258/jtt.2012.gth105
  contributor:
    fullname: Cassimatis
– volume: 12
  start-page: 893
  year: 2016
  ident: HC19017R44
  publication-title: Res Social Adm Pharm.
  doi: 10.1016/j.sapharm.2015.11.001
  contributor:
    fullname: Norris
– volume: 4
  year: 2017
  ident: HC19017R48
  publication-title: Cochrane Database Syst Rev.
  contributor:
    fullname: Adler
– volume: 86
  start-page: 304
  year: 2011
  ident: HC19017R16
  publication-title: Mayo Clin Proc.
  doi: 10.4065/mcp.2010.0575
  contributor:
    fullname: Brown
– volume: 46
  start-page: 1125
  year: 2008
  ident: HC19017R39
  publication-title: Med Care.
  doi: 10.1097/MLR.0b013e31817924d2
  contributor:
    fullname: Karve
SSID ssj0000463022
Score 2.236736
Snippet Identifies levels of sub-optimal adherence to oral hypoglycaemic medicines among people with type 2 diabetes, and those patient groups who may need additional...
INTRODUCTION Poor adherence to oral hypoglycaemic medicines is a key contributor to therapy failure and sub-optimal glycaemic control among people with type 2...
ABSTRACT INTRODUCTIONPoor adherence to oral hypoglycaemic medicines is a key contributor to therapy failure and sub-optimal glycaemic control among people with...
SourceID proquest
crossref
pubmed
nlnz
SourceType Aggregation Database
Index Database
StartPage 265
SubjectTerms Hypoglycemic agents
Non-insulin-dependent diabetes
Patient compliance
Treatment
Title Using the Pharmaceutical Collection Database to identify patient adherence to oral hypoglycaemic medicines
URI https://natlib-primo.hosted.exlibrisgroup.com/primo-explore/search?query=any,contains,999018406402837&tab=innz&search_scope=INNZ&vid=NLNZ&offset=0
https://www.ncbi.nlm.nih.gov/pubmed/32171380
https://search.proquest.com/docview/2377679677
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swGBVbB6UvY_dl7YoGexveYku2o8ctu4RBxxgt5M18suR6JXVC4jykv76fbnayLbCNgBMsJwo6B-nou4mQ16KEciQVi4YyM6YbPoxgBBDxVFdDAfiy1fXPvmWTC_51mk77UF6bXdLKt-XNH_NK_gdVvIe4mizZf0C2-1G8gZ8RX7wiwnj9K4ydv99Ix-_1jmnamgPcIeAfoQWzVBmR-dNm5VabUE31Dajal5nFVpurX28W88vZpgQbNB8876s9Gnbha1W4bEpb5rqbwfEfXa1nLh-oudSrug8uHsO1Xnp3_wy24m8_LGHtLN0_auRt4znjrRJxH3aFi4qbSVEZ4b7UVQ3vptp4i1Jse950B0b8Np-jAEIQJmMjW_LtJxCIxbWFleGmKmbuOKhfSmeHprvkXpKL1ER8fpnGnQnOFEtDCeNSqU1X73xHR-QwfHVHrhw0s-Zm_1bESpLzB-S-x4G-d8R4SO7o5hE5PPOYPSZXlh8U-UF3-UF7ftDAD9rOaeAH9fygHT9Mq-EH3eEH7fjxhFx8_nQ-nkT-bI2oZDxpI8lymeSgkyTXsVB6aFKSAVdGnqEE10qa6HSphABZKWCcq5Kh1EvykcQNfZaypzga80Y_J7QSuDBkXIJKKw4Vk5DJSkgVqxKAyXxAaBjCwtOysKEPeVz4AR-QEzO0ha0Qiu_CeGtH3HiZTXWmAXkVhrzA2c-4tKDR8_WqSJipRiWyHJ955rDo-ggQvtjbckyOeu6ekIN2udYvUWO28tTaZk4tX24BLxF_3g
link.rule.ids 315,786,790,870,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Using+the+Pharmaceutical+Collection+Database+to+identify+patient+adherence+to+oral+hypoglycaemic+medicines&rft.jtitle=Journal+of+primary+health+care&rft.au=Kharjul%2C+Mangesh+D&rft.au=Cameron%2C+Claire&rft.au=Braund%2C+Rhiannon&rft.date=2019-09-01&rft.eissn=1172-6156&rft.volume=11&rft.issue=3&rft.spage=265&rft_id=info:doi/10.1071%2FHC19017&rft_id=info%3Apmid%2F32171380&rft.externalDocID=32171380
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1172-6164&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1172-6164&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1172-6164&client=summon